• Samba 65 00% 56.65%
    Joga2002 635.254 50% 63.63%
    Bra52 69 23.145% -63.25%
    Joga2002 635.254 50% 63.63%
  • HangSang20 370 400% -20%
    NasDaq4 33 00% 36%
    S&P5002 60 50% 10%
    HangSang20 370 400% -20%
    Dow17 56.23 41.89% -2.635%


  • EghtesadOnline: The average costs associated with childhood cancer treatment have increased by 27% in the eight months to Nov. 20 compared with the corresponding period of last fiscal year, says Arasb Ahmadian, managing director of Mahak, which supports children suffering from cancer in Iran.

  • EghtesadOnline: A knowledge-based company produced the pharmaceutical ingredient nano calcium carbonate, which can be used in making anticancer drugs, at industrial level.

  • EghtesadOnline: Nausea, vomiting and hair loss appear like clockwork with chemotherapy. Patients know to expect them and doctors, even those who don’t normally treat cancer, know how to handle them.

  • EghtesadOnline: For a fetus in the womb, it’s an enzyme that means life, a shield from a mother’s immune system that would otherwise fight the embryo as an infection. Gone rogue, it can mean death -- protecting malignant tumors from attacks by the body’s defenses.

  • EghtesadOnline: Iranian and Italian researchers seek holding international congresses and share mutual knowledge and technology.

  • EghtesadOnline: Iranian researchers are now capable of producing 'carboplatin' which is an anti-cancer drug.

  • EghtesadOnline: The Cell Therapy Group of Breast Cancer Research Center of Iran and the department of Molecular Cell Biology and Immunology of VU University Medical Center of the Netherlands are working in a joint project to test a new way to treat cancer cells.

  • EghtesadOnline: Dr. Ali M. Ardekani, director of Middle Eastern association for Cancer Research (MEACR) says that among the Middle East countries, Iran has begun a good way to prevent cancer.

  • SSoftware giant's AI health push follows similar efforts by IBM, Google's DeepMind and startups including Deep 6.

    EghtesadOnline: There are hundreds of new cancer drugs in development and new research published minute to minute, helping doctors treat patients with personalized combinations that target the specific building blocks of their disease. The problem is there's too much to read and too many drug combinations for doctors to choose the best option every time.